Related references
Note: Only part of the references are listed.Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
Roberta D'Ambrosio et al.
JOURNAL OF HEPATOLOGY (2022)
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis
Candid Villanueva et al.
JOURNAL OF HEPATOLOGY (2022)
New terms for fatty liver disease other than MAFLD: Time for a reality check
Nahum Mendez-Sanchez et al.
JOURNAL OF HEPATOLOGY (2022)
In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent
Therese Bittermann et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
Dalila Costa et al.
JOURNAL OF HEPATOLOGY (2021)
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes
Mathias Jachs et al.
GUT (2021)
A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement
Elisa Pose et al.
JOURNAL OF HEPATOLOGY (2021)
Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity
Lisette A. P. Krassenburg et al.
JOURNAL OF HEPATOLOGY (2021)
Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case-control study
Xiaomei Xu et al.
BMJ OPEN (2021)
Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis
Manuel Rodriguez et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis
Meredith M. Pearson et al.
HEPATOLOGY COMMUNICATIONS (2021)
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy
Mattias Mandorfer et al.
HEPATOLOGY (2020)
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort
Elizabeth C. Verna et al.
JOURNAL OF HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Serum MicroRNA Signatures in Recovery From Acute and Chronic Liver Injury and Selection for Liver Transplantation
Siamak Salehi et al.
LIVER TRANSPLANTATION (2020)
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Sabela Lens et al.
JOURNAL OF HEPATOLOGY (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Burden of liver diseases in the world
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2019)
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Candid Villanueva et al.
LANCET (2019)
Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation
Jeanne-Marie Giard et al.
LIVER TRANSPLANTATION (2019)
Efficacy of direct-acting antivirals: UK real-world data from a well-characterised predominantly cirrhotic HCV cohort
Lucia Macken et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network ActivityLINA cohort)
Ivan Gentile et al.
HEPATOLOGY INTERNATIONAL (2019)
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience
Silvia Martini et al.
LIVER INTERNATIONAL (2018)
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection
Omar El-Sherif et al.
GASTROENTEROLOGY (2018)
Clinical states of cirrhosis and competing risks
Gennaro D'Amico et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
JOURNAL OF HEPATOLOGY (2018)
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting
Giovanni Perricone et al.
LIVER INTERNATIONAL (2018)
Liver transplantation and alcoholic liver disease: History, controversies, and considerations
Claudio Augusto Marroni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease
Carolin Lackner et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
Juan Manuel Pascasio et al.
JOURNAL OF HEPATOLOGY (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study
Aloysious D. Aravinthan et al.
TRANSPLANT INTERNATIONAL (2017)
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
Luca Saverio Belli et al.
JOURNAL OF HEPATOLOGY (2016)
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
Mattias Mandorfer et al.
JOURNAL OF HEPATOLOGY (2016)
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
Graham R. Foster et al.
JOURNAL OF HEPATOLOGY (2016)
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
Michelle C. M. Cheung et al.
JOURNAL OF HEPATOLOGY (2016)
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Michael Manns et al.
LANCET INFECTIOUS DISEASES (2016)
Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation
Andres F. Carrion et al.
LIVER TRANSPLANTATION (2016)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis
Jeong Won Jang et al.
HEPATOLOGY (2015)
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
M. P. Curry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis
Soon Sun Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
Thomas Reiberger et al.
JOURNAL OF HEPATOLOGY (2013)
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study
M. Pinter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
Cheng-Yuan Peng et al.
JOURNAL OF HEPATOLOGY (2012)
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study
George V. Papatheodoridis et al.
GUT (2011)
Efficacy and Safety of Entecavir Versus Adefovir in Chronic Hepatitis B Patients With Hepatic Decompensation: A Randomized, Open-Label Study
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
Maria Stepanova et al.
GUT (2010)
Clinical Course of Alcoholic Liver Cirrhosis: A Danish Population-Based Cohort Study
Peter Jepsen et al.
HEPATOLOGY (2010)
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
Ju Hyun Shim et al.
JOURNAL OF HEPATOLOGY (2010)
Risk assessment for the development of hepatocellular carcinoma: According to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease
Jong Ryul Eun et al.
JOURNAL OF HEPATOLOGY (2010)
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension
Spilios Manolakopoulos et al.
JOURNAL OF HEPATOLOGY (2009)
Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats
Thomas Reiberger et al.
JOURNAL OF HEPATOLOGY (2009)
Angiogenesis in liver disease
Mercedes Fernandez et al.
JOURNAL OF HEPATOLOGY (2009)
Einfluß von Alkohol auf die Hämodynamik der Pfortader bei nutritiv-toxischer Leberzirrhose
C.-P. Klein et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
Cristina Ripoll et al.
GASTROENTEROLOGY (2007)
Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B
N Nikolaidis et al.
CLINICAL TRANSPLANTATION (2005)
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
FY Yao et al.
HEPATOLOGY (2001)
Share Paper
